Logo image of MKL

MARKEL GROUP INC (MKL) Stock Fundamental Analysis

USA - NYSE:MKL - US5705351048 - Common Stock

1954.07 USD
-9.96 (-0.51%)
Last: 9/12/2025, 8:04:00 PM
1954.07 USD
0 (0%)
After Hours: 9/12/2025, 8:04:00 PM
Fundamental Rating

4

Overall MKL gets a fundamental rating of 4 out of 10. We evaluated MKL against 146 industry peers in the Insurance industry. While MKL is still in line with the averages on profitability rating, there are concerns on its financial health. MKL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year MKL was profitable.
MKL had a positive operating cash flow in the past year.
MKL had positive earnings in 4 of the past 5 years.
MKL had a positive operating cash flow in each of the past 5 years.
MKL Yearly Net Income VS EBIT VS OCF VS FCFMKL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

The Return On Assets of MKL (3.22%) is better than 68.49% of its industry peers.
The Return On Equity of MKL (12.42%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 3.22%
ROE 12.42%
ROIC N/A
ROA(3y)2.38%
ROA(5y)2.8%
ROE(3y)8.69%
ROE(5y)9.72%
ROIC(3y)N/A
ROIC(5y)N/A
MKL Yearly ROA, ROE, ROICMKL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

The Profit Margin of MKL (13.07%) is better than 75.34% of its industry peers.
In the last couple of years the Profit Margin of MKL has declined.
MKL has a Operating Margin of 20.40%. This is amongst the best in the industry. MKL outperforms 80.14% of its industry peers.
MKL's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 20.4%
PM (TTM) 13.07%
GM N/A
OM growth 3Y-3.99%
OM growth 5Y-3%
PM growth 3Y-6.22%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
MKL Yearly Profit, Operating, Gross MarginsMKL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

3

2. Health

2.1 Basic Checks

MKL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MKL has less shares outstanding
MKL has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MKL has a worse debt to assets ratio.
MKL Yearly Shares OutstandingMKL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
MKL Yearly Total Debt VS Total AssetsMKL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

MKL has a debt to FCF ratio of 2.13. This is a good value and a sign of high solvency as MKL would need 2.13 years to pay back of all of its debts.
With a Debt to FCF ratio value of 2.13, MKL perfoms like the industry average, outperforming 52.74% of the companies in the same industry.
A Debt/Equity ratio of 0.25 indicates that MKL is not too dependend on debt financing.
MKL's Debt to Equity ratio of 0.25 is fine compared to the rest of the industry. MKL outperforms 63.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.13
Altman-Z N/A
ROIC/WACCN/A
WACC8.01%
MKL Yearly LT Debt VS Equity VS FCFMKL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MKL Yearly Current Assets VS Current LiabilitesMKL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2022 2023 2024 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

MKL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.53%, which is quite good.
The Earnings Per Share has been growing by 13.39% on average over the past years. This is quite good.
Looking at the last year, MKL shows a small growth in Revenue. The Revenue has grown by 1.66% in the last year.
Measured over the past years, MKL shows a quite strong growth in Revenue. The Revenue has been growing by 11.78% on average per year.
EPS 1Y (TTM)9.53%
EPS 3Y4.51%
EPS 5Y13.39%
EPS Q2Q%-48.52%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y8.97%
Revenue growth 5Y11.78%
Sales Q2Q%20.56%

3.2 Future

MKL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.31% yearly.
The Revenue is expected to grow by 3.46% on average over the next years.
EPS Next Y32.97%
EPS Next 2Y22.72%
EPS Next 3Y18.61%
EPS Next 5Y13.31%
Revenue Next Year-4.88%
Revenue Next 2Y-1.8%
Revenue Next 3Y0.45%
Revenue Next 5Y3.46%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MKL Yearly Revenue VS EstimatesMKL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
MKL Yearly EPS VS EstimatesMKL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 50 -50 100

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 31.31, the valuation of MKL can be described as expensive.
79.45% of the companies in the same industry are cheaper than MKL, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.30. MKL is around the same levels.
Based on the Price/Forward Earnings ratio of 17.77, the valuation of MKL can be described as rather expensive.
Based on the Price/Forward Earnings ratio, MKL is valued a bit more expensive than the industry average as 66.44% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.73, MKL is valued a bit cheaper.
Industry RankSector Rank
PE 31.31
Fwd PE 17.77
MKL Price Earnings VS Forward Price EarningsMKL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

65.07% of the companies in the same industry are more expensive than MKL, based on the Enterprise Value to EBITDA ratio.
MKL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 12.07
EV/EBITDA 6.89
MKL Per share dataMKL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800 1K

4.3 Compensation for Growth

MKL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MKL's earnings are expected to grow with 18.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.95
PEG (5Y)2.34
EPS Next 2Y22.72%
EPS Next 3Y18.61%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MKL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARKEL GROUP INC

NYSE:MKL (9/12/2025, 8:04:00 PM)

After market: 1954.07 0 (0%)

1954.07

-9.96 (-0.51%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners83.5%
Inst Owner Change-2.44%
Ins Owners1.4%
Ins Owner Change0.35%
Market Cap24.72B
Analysts51.43
Price Target2018.58 (3.3%)
Short Float %1.56%
Short Ratio4.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend2.78
Dividend Growth(5Y)N/A
DP1.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.29%
Min EPS beat(2)-45.1%
Max EPS beat(2)36.52%
EPS beat(4)2
Avg EPS beat(4)-18.28%
Min EPS beat(4)-119.59%
Max EPS beat(4)55.06%
EPS beat(8)5
Avg EPS beat(8)-22.64%
EPS beat(12)8
Avg EPS beat(12)-9.57%
EPS beat(16)12
Avg EPS beat(16)4.5%
Revenue beat(2)1
Avg Revenue beat(2)4.72%
Min Revenue beat(2)-6.65%
Max Revenue beat(2)16.08%
Revenue beat(4)1
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-6.65%
Max Revenue beat(4)16.08%
Revenue beat(8)3
Avg Revenue beat(8)4.69%
Revenue beat(12)6
Avg Revenue beat(12)5.81%
Revenue beat(16)7
Avg Revenue beat(16)3.3%
PT rev (1m)0.89%
PT rev (3m)1.93%
EPS NQ rev (1m)1.74%
EPS NQ rev (3m)-4.16%
EPS NY rev (1m)-2.31%
EPS NY rev (3m)0.9%
Revenue NQ rev (1m)0.6%
Revenue NQ rev (3m)-1.84%
Revenue NY rev (1m)3.29%
Revenue NY rev (3m)2.18%
Valuation
Industry RankSector Rank
PE 31.31
Fwd PE 17.77
P/S 1.5
P/FCF 12.07
P/OCF 10.91
P/B 1.43
P/tB 1.92
EV/EBITDA 6.89
EPS(TTM)62.42
EY3.19%
EPS(NY)109.96
Fwd EY5.63%
FCF(TTM)161.91
FCFY8.29%
OCF(TTM)179.08
OCFY9.16%
SpS1300.72
BVpS1369.02
TBVpS1017.74
PEG (NY)0.95
PEG (5Y)2.34
Profitability
Industry RankSector Rank
ROA 3.22%
ROE 12.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 20.4%
PM (TTM) 13.07%
GM N/A
FCFM 12.45%
ROA(3y)2.38%
ROA(5y)2.8%
ROE(3y)8.69%
ROE(5y)9.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.99%
OM growth 5Y-3%
PM growth 3Y-6.22%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.13
Debt/EBITDA 1.18
Cap/Depr 63.44%
Cap/Sales 1.32%
Interest Coverage 250
Cash Conversion 61.24%
Profit Quality 95.24%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)81.13%
Cap/Depr(5y)63.91%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.53%
EPS 3Y4.51%
EPS 5Y13.39%
EPS Q2Q%-48.52%
EPS Next Y32.97%
EPS Next 2Y22.72%
EPS Next 3Y18.61%
EPS Next 5Y13.31%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y8.97%
Revenue growth 5Y11.78%
Sales Q2Q%20.56%
Revenue Next Year-4.88%
Revenue Next 2Y-1.8%
Revenue Next 3Y0.45%
Revenue Next 5Y3.46%
EBIT growth 1Y13.76%
EBIT growth 3Y4.62%
EBIT growth 5Y8.42%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-20.41%
FCF growth 3Y3.19%
FCF growth 5Y15.24%
OCF growth 1Y-19.01%
OCF growth 3Y4.48%
OCF growth 5Y15.28%